A Possible Mechanism of NK Cell-lineage Granular Lymphocyte Proliferative Disorder (NK-GLPD) in a Patient with Chronic Active Epstein-Barr Virus Infection (CAEBV) and Severe Hypersensitivity to Mosquito Bites (SHMB).
Authors:
Open Access
- 1 January 2002
- journal article
- case report
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 41 (8) , 651-656
Abstract
We report the case of a young female patient with chronic active Epstein-Barr virus infection (CAEBV) and severe hypersensitivity to mosquito bites (SHMB). She showed a marked increase of NK cell population in peripheral blood. The NK cell population was suggested to be infected with EBV, and to be oligoclonal by Southern blotting using an EBV genome terminal-repeat probe. The NK cells aberrantly expressed CD25, a high affinity receptor for IL-2, and showed an augmented in vitro proliferative response to IL-2. Moreover, they also showed enhanced expression of both Fas-ligand and Bcl-2, and resistance to in vitro Fasinduced apoptotic cell death (Fas-ACD). Taken together, these observations suggested that both the augmentation of proliferative response to IL-2 and the decrease in Fas-ACD may cause NK cell lineage granular lymphocyte proliferative disorder (NK-GLPD) in patients with CAEBV and SHMB. (Internal Medicine 41: 651-656, 2002)Keywords
This publication has 19 references indexed in Scilit:
- Characterization of Epstein–Barr virus (EBV)-infected natural killer (NK) cell proliferation in patients with severe mosquito allergy; establishment of an IL-2-dependent NK-like cell lineClinical and Experimental Immunology, 1999
- Severe mosquito bite hypersensitivity, natural killer cell leukaemia, latent or chronic active Epstein–Barr virus infection and hydroa vacciniforme‐like eruptionBritish Journal of Dermatology, 1998
- Fas ligand in human serumNature Medicine, 1996
- The Association of Epstein-Barr Virus (Ebv) with T Cell Lymphoproliferations and hodgkin's Disease: Two New Developments in the Ebv Field1993
- Induction of bcl-2 expression by epstein-barr virus latent membrane protein 1 protects infected B cells from programmed cell deathCell, 1991
- Severe hypersensitivity to mosquito bites associated with natural killer cell lymphocytosisArchives of Dermatology, 1990
- Specific binding and release of cells from beads using cleavable tetrameric antibody complexesJournal of Immunological Methods, 1989
- Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like diseaseNature, 1988
- SUCCESSFUL TREATMENT OF CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION WITH RECOMBINANT INTERLEUKIN-2The Lancet, 1987
- The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferationCell, 1986